Abstract: The present invention presents a Kunitz-type recombinant inhibitor obtained from a gene cloned from a cDNA library of salivary glands of the Amblyomma cajennense, and the inhibitor named Amblyomin-X has molecular mass of 13,500 Da.
Type:
Grant
Filed:
March 14, 2007
Date of Patent:
May 14, 2013
Assignee:
Coinfair-Consórcio De Indústrias Farmacêuticas
Inventors:
Durvanei Augusto Maria, Ana Marisa Chudzinski-Tavassi, Isabel De Fatima Correia Batista, Paulo Lee Ho